warfarin

Documents about warfarin

• Patient Training About the Safety of Warfarin Therapy#868045ClinicalTrials.gov
• Drug Interaction Study Between AZD3480 and Warfarin#907304ClinicalTrials.gov
• The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin#980958ClinicalTrials.gov
• Improving Warfarin dosing by applying machine learning to a small African data set#400102OpenUCT
• Duloxetine - Warfarin Pharmacodynamic Study#804733ClinicalTrials.gov
• A Prospective Cohort Study on Warfarin Personalized Medication#856694ClinicalTrials.gov
• Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"#894811ClinicalTrials.gov
• Simple Warfarin Dosing Algorithm Study#897124ClinicalTrials.gov
• Assessing the Ability of Warfarin Treated Patients to Predict Their INR#862110ClinicalTrials.gov
• Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation#7090OpenAlex
• Dabigatran versus Warfarin in Patients with Atrial Fibrillation#6905OpenAlex
• Clinical and Economic Implications of Genetic Testing for Warfarin Management#966973ClinicalTrials.gov
• Protocol for Improvement of Therapy With Warfarin#981190ClinicalTrials.gov
• Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects#870885ClinicalTrials.gov
• Impact of Pharmacist-Managed warfarin Therapy on Clinical Outcomes in Hospitalized Patients: A systematic Review#260037Indonesian Journal of Pharmacy
• Pharmacist Interventions in Rural Elderly Warfarin Patients#813110ClinicalTrials.gov
• Testing Strategies to Improving Warfarin Adherence#868731ClinicalTrials.gov
• Warfarin affects acute inflammatory response induced by subcutaneous polyvinyl sponge implantation in rats#643948IBISS
• Randomized Trial of Interventions to Improve Warfarin Adherence#854621ClinicalTrials.gov
• Drug Interaction Between Paracetamol and Warfarin#864047ClinicalTrials.gov
• A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin#868153ClinicalTrials.gov
• Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study#912070ClinicalTrials.gov
• Validation of Criteria Used to Predict Warfarin Dosing Decisions#640244BYU ScholarsArchive
• Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation#895379ClinicalTrials.gov
• A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin#866956ClinicalTrials.gov
• Warfarin Patient Self-management Implementation in the US Healthcare System#967620ClinicalTrials.gov
• A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam#907669ClinicalTrials.gov
• Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin#913137ClinicalTrials.gov
• The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin#811198ClinicalTrials.gov
• Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial#880993ClinicalTrials.gov
• A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies#897857ClinicalTrials.gov
• Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients#860222ClinicalTrials.gov
• A Drug Interaction Study With Albiglutide and Warfarin#121264ClinicalTrials.gov
• Insight into the synthesis of warfarin and its promiscuous derivatives#706620PhilArchive
• Vitamin K for Perioperative Warfarin Management#853778ClinicalTrials.gov
• Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy#911657ClinicalTrials.gov
• Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）#982726ClinicalTrials.gov
• Drug Interaction Study of Warfarin and MT-3995#890370ClinicalTrials.gov
• Image 2_Comparison of CYP2C9 activity between Ethiopian and non-Ethiopian Jews: an interethnic study of (S)-warfarin pharmacokinetic and pharmacodynamic.pdf#300629Figshare
• Image 3_Comparison of CYP2C9 activity between Ethiopian and non-Ethiopian Jews: an interethnic study of (S)-warfarin pharmacokinetic and pharmacodynamic.pdf#300630Figshare
• Image 1_Comparison of CYP2C9 activity between Ethiopian and non-Ethiopian Jews: an interethnic study of (S)-warfarin pharmacokinetic and pharmacodynamic.pdf#300631Figshare
• Table 1_Comparison of CYP2C9 activity between Ethiopian and non-Ethiopian Jews: an interethnic study of (S)-warfarin pharmacokinetic and pharmacodynamic.docx#300632Figshare
• Table 2_Comparison of CYP2C9 activity between Ethiopian and non-Ethiopian Jews: an interethnic study of (S)-warfarin pharmacokinetic and pharmacodynamic.docx#300633Figshare
• A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers#831916ClinicalTrials.gov
• Warfarin Anticoagulation in Patients in Sub-Saharan Africa#872671ClinicalTrials.gov
• Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque#981731ClinicalTrials.gov
• Prospective Trial of a Validated Algorithm for Warfarin Dosing#813670ClinicalTrials.gov
• Pharmacogenetic Study of Warfarin Dose-Response: a Prospective Trial#968331ClinicalTrials.gov
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management#839687ClinicalTrials.gov
• Gene-guided Warfarin for Anticoagulation Therapy#897908ClinicalTrials.gov